AwesomeCapital
Monday, June 24, 2019
NGM started at Buy by Stifel
A
nalyst Derek Archila initiates coverage on NGM Biopharmaceuticals (NASDAQ: NGM) with a Buy
https://www.streetinsider.com/Analyst+Comments/Stifel+Starts+NGM+Biopharmaceuticals+%28NGM%29+at+Buy/15640478.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.